Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Braulio, Mestre"'
Autor:
Medina, Elías A. Gracia, Caballero, Brenda Benítez, Miguel, Karen López, Gutiérrez, Zaili Aleaga, Fernández, Braulio Mestre, Tul, Luis E. Alsina, Rodríguez, Luis E. Martín, Guerrero, Orlando Valdés, Varela, Idania G. Sánchez, Bernardo, María de la Caridad Campos, Montero, Yoandri Calderón, Ortiz, Mónica Ramos, Carrasco, Julien Martínez, Torres, Keytia Peña, Prado, Yenia I. Díaz, Rubio, María Caridad, Braojo, Inés M. Pérez
Publikováno v:
In Cancer Treatment and Research Communications 2023 34
Autor:
Elías A. Gracia Medina, Brenda Benítez Caballero, Karen López Miguel, Zaili Aleaga Gutiérrez, Braulio Mestre Fernández, Luis E. Alsina Tul, Luis E. Martín Rodríguez, Orlando Valdés Guerrero, Idania G. Sánchez Varela, María de la Caridad Campos Bernardo, Yoandri Calderón Montero, Mónica Ramos Ortiz, Julien Martínez Carrasco, Keytia Peña Torres, Yenia I. Díaz Prado, María Caridad Rubio, Inés M. Pérez Braojo
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100670- (2023)
PURPOSE: Dual HER2 blockade chemotherapy is the standard of care for localized HER2+ breast cancer (BC). However, despite the efficacy of neoadjuvant therapy, relapses occurring in around 10% of patients highlight the need to improve its clinical app
Externí odkaz:
https://doaj.org/article/eae1f9a3cbab4ede850c096eb5bfbbb8
Autor:
Tania Crombet Ramos, Braulio Mestre Fernández, Zaima Mazorra Herrera, Normando E. Iznaga Escobar
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasis of the cancer cells. Nimotuzumab is an engineered, intermediate affinity anti-EGFR antibody, that apart from other drugs in its class, is very safe an
Externí odkaz:
https://doaj.org/article/bceb0de3d3f9425f805305ce0060dcf0
Autor:
Aliz M. Vega, Mayte Robaina, Braulio Mestre, Tania Crombet, Mayra Ramos, Lázara Kenia Ramírez García, Yuliannis Santiesteban, Marta Osorio, Aliuska Frías, Yanela Santiesteban, Leslie Pérez, Amparo Macías, M. Alvarez, Carmen Viada
Publikováno v:
Bionatura. 5:1056-1062
Nimotuzumab, humanized monoclonal antibody, directed against the epidermal growth factor receptor: highly expressed protein in malignant tumors of epithelial origin. It has been registered for head and neck tumors since 2002. To determine the effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71e64b82d080b960a4974947e97f60a8
https://doi.org/10.21931/rb/2020.05.01.8
https://doi.org/10.21931/rb/2020.05.01.8
Autor:
Maribel G, Vallespi, Braulio, Mestre, Maria A, Marrero, Rolando, Uranga, Diana, Rey, Martha, Lugiollo, Mircea, Betancourt, Kirenia, Silva, Danay, Corrales, Yanet, Lamadrid, Yamilka, Rodriguez, Anaelys, Maceo, Pedro P, Chaviano, Gilda, Lemos, Ania, Cabrales, Freya M, Freyre, Hector, Santana, Hilda E, Garay, Brizaida, Oliva, Julio R, Fernandez
Publikováno v:
International journal of cancerREFERENCES. 149(6)
CIGB-552 is a synthetic peptide that interacts with COMMD1 and upregulates its protein levels. The objectives of this phase I study were safety, pharmacokinetic profile, evaluation of the lymphocytes CD4+ and CD8+ and preliminary activity in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d3909af6a241c4044657bc43099172e
https://pubmed.ncbi.nlm.nih.gov/34019700
https://pubmed.ncbi.nlm.nih.gov/34019700
Autor:
Braulio Mestre Fernández, Zaima Mazorra Herrera, Normando E Iznaga Escobar, Tania Crombet Ramos
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasis of the cancer cells. Nimotuzumab is an engineered, intermediate affinity anti-EGFR antibody, that apart from other drugs in its class, is very safe an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b43b61657cb81f9a4f9027ed1b9c5f0
Autor:
Helga Candanedo, Ivonne Chon Rivas, Eduardo Sanz, Yelena Cuervo, Juan J. Lence, Gagmar Alfonso, Braulio Mestre, Johannes R Mestre Cabello, Martha Lugoyo, José Alert Silva
Publikováno v:
Journal of Cancer Science & Therapy. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77ef6f976b36d9b79becf4dad0747c8
https://doi.org/10.4172/1948-5956.1000562
https://doi.org/10.4172/1948-5956.1000562